Stay informed by signing up for our email alerts here: https://bit.ly/44RHGgU #CYTH #StayConnected
Cyclo Therapeutics, Inc.
制药业
Gainesville，Florida 2,085 位关注者
Dedicated to developing life-changing medicines for patients and families living with challenging diseases
关于我们
Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with disease. The Company’s Trappsol? Cyclo?, an orphan drug designated product in the United States and Europe, is the subject of four formal clinical trials for Niemann-Pick Disease Type C, a rare and fatal genetic disease, (www.ClinicalTrials.gov NCT02939547, NCT02912793, NCT03893071 and NCT04860960). The Company is conducting a Phase 2b clinical trial using Trappsol? Cyclo? intravenously in early Alzheimer’s disease (NCT05607615) based on encouraging data from an Expanded Access program for Alzheimer’s disease (NCT03624842). Additional indications for the active ingredient in Trappsol? Cyclo? are in development. For additional information, visit the Company’s website: www.cyclotherapeutics.com.
- 网站
-
https://www.cyclotherapeutics.com/
Cyclo Therapeutics, Inc.的外部链接
- 所属行业
- 制药业
- 规模
- 2-10 人
- 总部
- Gainesville，Florida
- 类型
- 上市公司
- 创立
- 1990
- 领域
- cyclodextrins、cyclodextrin derivatives、cyclodextrin complexes、cyclodextrin chemistry、hydroxypropyl、gamma、Trappsol(R)、Cyclo(TM)和Aquaplex(R)
地点
-
主要
获取路线
6714 NW 16th St
US，Florida，Gainesville
Cyclo Therapeutics, Inc.员工
动态
-
We are dedicated to developing life changing medicines. Learn more about our team here: https://bit.ly/3Y9LdWD #CYTH
-
-
Leveraging over three decades of experience with cyclodextrins, we are advancing clinically de-risked programs aimed at addressing diseases with significant unmet medical needs. Learn more: https://bit.ly/3OMEDzh #CYTH
-
-
Cyclo Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update. https://bit.ly/4ftwzRu #NiemannPick #NPC1
-
Alzheimer’s disease impacts over 5 million people in the U.S. and is the 6th leading cause of death in the country. Explore our pipeline to see how we are working to make a difference in the fight against #AlzheimersDisease. https://bit.ly/3WmEPvy #CYTH #AlzheimersAwareness Alzheimer's Association?
-
-
We are proud to have sponsored the VIII Latin American Course on Lysosomal Storage Diseases, which took place in Foz do Igua?u, Brazil. It was a fantastic event, and we look forward to partnering again in the future! #CYTH #NiemannPick #NPC1
-
-
In recognition of #NationalFamilyCaregiversMonth, we extend our sincere appreciation to all who care for and support those affected by #NiemannPick disease. #CYTH #NPC1
-
-
November is National Alzheimer’s Disease Awareness Month. Throughout the month, we’ll share information and resources to help us all understand and advocate for change. Together, we can make a difference. Alzheimer's Association? #AlzheimersDisease #AlzheimersAwareness #CYTH
-
-
As Niemann-Pick Awareness Month wraps up, we encourage you to learn more and support the cause at https://bit.ly/46lCrYE. Let's raise awareness and make a difference. #CYTH #NiemannPickAwarenessMonth #NiemannPick #NPC1
-
-
In recognition of #NiemmanPickAwarenessMonth we encourage you to visit https://bit.ly/3Yfo8Dk to learn more about registries and the important role they play in advancing research and improving lives for our community. #CYTH #NiemannPick #NPC1
INPDR International Niemann-Pick Disease Registry
https://inpdr.org